Ontario Ginseng Growers Association Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2001
NCT00219960
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

ginseng (1 trial)

panax quinquefolius (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperglycemia (Phase 3)

Hypertension (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2